Big data and targeted machine learning in action to assist medical decision in the ICU

Romain Pirracchio; Mitchell J Cohen; Ivana Malenica; Jonathan Cohen; Antoine Chambaz; Maxime Cannesson; Christine Lee; Matthieu Resche-Rigon; Alan Hubbard; ACTERREA Research Group

doi:10.1016/j.accpm.2018.09.008

Big data and targeted machine learning in action to assist medical decision in the ICU

Anaesth Crit Care Pain Med. 2019 Aug;38(4):377-384. doi: 10.1016/j.accpm.2018.09.008. Epub 2018 Oct 16.

Authors

Romain Pirracchio¹, Mitchell J Cohen², Ivana Malenica³, Jonathan Cohen³, Antoine Chambaz⁴, Maxime Cannesson⁵, Christine Lee⁶, Matthieu Resche-Rigon⁷, Alan Hubbard³; ACTERREA Research Group

Affiliations

¹ Division of biostatistics, School of Public Health, university of California Berkeley, CA, USA; Department of anesthesia and perioperative medicine, university of California San Francisco, CA, USA; Service d'anesthésie-réanimation, hôpital Européen Georges-Pompidou, université Paris Descartes, Sorbonne Paris Cite, 75015 Paris, France; Service de biostatistique et informatique médicale, hôpital Saint-Louis, Inserm UMR-1153, université Paris Diderot, Sorbonne Paris Cite, 75010 Paris, France. Electronic address: romain.pirracchio@aphp.fr.
² Department of surgery, university of Colorado Denver, Colorado, USA.
³ Division of biostatistics, School of Public Health, university of California Berkeley, CA, USA.
⁴ MAP5 (UMR CNRS 8145), université Paris Descartes, 75006 Paris, France.
⁵ Department of anesthesiology and perioperative medicine, university of California Los Angeles, CA, USA; Department of bioengineering, university of California Irvine, CA, USA.
⁶ Department of bioengineering, university of California Irvine, CA, USA.
⁷ Service de biostatistique et informatique médicale, hôpital Saint-Louis, Inserm UMR-1153, université Paris Diderot, Sorbonne Paris Cite, 75010 Paris, France.

PMID: 30339893
DOI: 10.1016/j.accpm.2018.09.008

Abstract

Historically, personalised medicine has been synonymous with pharmacogenomics and oncology. We argue for a new framework for personalised medicine analytics that capitalises on more detailed patient-level data and leverages recent advances in causal inference and machine learning tailored towards decision support applicable to critically ill patients. We discuss how advances in data technology and statistics are providing new opportunities for asking more targeted questions regarding patient treatment, and how this can be applied in the intensive care unit to better predict patient-centred outcomes, help in the discovery of new treatment regimens associated with improved outcomes, and ultimately how these rules can be learned in real-time for the patient.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review

MeSH terms

Big Data*
Decision Support Systems, Clinical*
Forecasting
Humans
Intensive Care Units*
Machine Learning*
Precision Medicine*

Abstract

Publication types

MeSH terms

Grants and funding